Brought to you by 
MolSoft, Syrrx in 10-year drug discovery deal
10 Jul 2001
Executive Summary
MolSoft (molecular modeling; bioinformatics) has signed a 10-year agreement with Syrrx (protein structure identification) to speed up the structure-guided drug discovery process for pharma and biotech companies.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Large Molecule
-
Drug Discovery Tools
- Bioinformatics
- Genomics-Proteomics
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
MolSoft, Syrrx in 10-year drug discovery deal
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice